The Sofia SARS Antigen FIA is a lateral flow immunofluorescent sandwich assay that is used with the Sofia and Sofia 2 instrument intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal (NS) swab specimens directly from individuals who are suspected of COVID- 19 by their healthcare provider within the first five days of the onset of symptoms.
Key Benefits
Accurate, objective and automated results in 15 minutes
Nasal specimens
Accurate detection with direct samples
Results in 15 minutes
Kit includes 25 sterile nasal swabs and a set of positive and negative control swabs
Room temperature storage
The Sofia SARS Antigen FIA does not differentiate between SARS-CoV and SARS-CoV-2.
